Passionate MannKind (MNKD) retail investors often contemplate big time buyouts by big pharma, market caps that approach $10 billion, and a situation where the stock goes up to levels which create millionaires. Not a week goes by where there is not some comment about a buyout from Amgen (AMGN), Roche ([[RHHBF]], [[RHHBY]]), Eli Lilly (LLY), or some other big ticket pharma with billions in cash looking for something to spend it on. Not a day goes by without seeing someone comment that MannKind is 'massively undervalued'. Meanwhile, the company is piling up losses,